HNRB Stock Chart & Stats
€42.00
€0.40(0.96%)
At close: 4:00 PM EDT
€42.00
€0.40(0.96%)
Day’s Range― - ―
52-Week Range€36.80 - €45.80
Previous CloseN/A
Volume0.00
Average Volume (3M)35.00
Market Cap
€30.60B
Enterprise Value€39.33K
Total Cash (Recent Filing)€1.06B
Total Debt (Recent Filing)€4.13B
Price to Earnings (P/E)3.4
Beta0.41
Next Earnings
Nov 09, 2026EPS Estimate
0.92Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)3.79
Shares Outstanding723,582,800
10 Day Avg. Volume36
30 Day Avg. Volume35
Financial Highlights & Ratios
PEG Ratio1.41
Price to Book (P/B)2.48
Price to Sales (P/S)1.34
P/FCF Ratio5.64
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)3.8
Revenue Forecast (FY)€26.81B
Bulls Say, Bears Say
Bulls Say
Strong Underwriting ProfitabilityThe combined ratio provides evidence of disciplined pricing, risk selection and claims management. Operating well below target gives Hannover Re resilience against catastrophe volatility and supports durable underwriting profitability.
Robust CapitalizationA high solvency ratio and strong internal capital generation provide substantial capacity to absorb underwriting shocks, support premium growth and maintain strategic flexibility without relying heavily on external funding.
Premium And New Business GrowthRenewal momentum and expanding contractual service margins indicate sustained demand for Hannover Re’s risk-transfer solutions. Growth across P&C and Life & Health can broaden earnings capacity and improve future revenue visibility.
Bears Say
Reinsurance Pricing Is SofteningLower risk-adjusted prices can compress future underwriting margins, particularly in property catastrophe business. If market competition persists, Hannover Re may need stricter selection or accept slower premium growth to protect returns.
Life & Health Claims And Assumption VolatilityLife & Health profitability depends on long-duration assumptions for morbidity, mortality and claims behavior. Adverse revisions or localized experience can increase reserves and reduce earnings predictability despite portfolio growth.
Inconsistent Operating Profitability And Cash ConversionVolatile operating margins and weaker free-cash-flow conversion make reported earnings harder to normalize and assess. This may constrain confidence in recurring profitability, especially when claims, reserves and investment results fluctuate.
Hannover Rueck SE News
HNRB FAQ
What was Hannover Rueck SE’s price range in the past 12 months?
Hannover Rueck SE lowest stock price was €36.80 and its highest was €45.80 in the past 12 months.
What is Hannover Rueck SE’s market cap?
Hannover Rueck SE’s market cap is €30.60B.
When is Hannover Rueck SE’s upcoming earnings report date?
Hannover Rueck SE’s upcoming earnings report date is Nov 09, 2026 which is in 73 days.
How were Hannover Rueck SE’s earnings last quarter?
Hannover Rueck SE released its earnings results on Aug 12, 2026. The company reported €0.952 earnings per share for the quarter, beating the consensus estimate of €0.913 by €0.039.
Is Hannover Rueck SE overvalued?
According to Wall Street analysts Hannover Rueck SE’s price is currently Overvalued.
Does Hannover Rueck SE pay dividends?
Hannover Rueck SE does not currently pay dividends.
What is Hannover Rueck SE’s EPS estimate?
Hannover Rueck SE’s EPS estimate is 0.92.
How many shares outstanding does Hannover Rueck SE have?
Hannover Rueck SE has 723,582,800 shares outstanding.
What happened to Hannover Rueck SE’s price movement after its last earnings report?
Hannover Rueck SE reported an EPS of €0.952 in its last earnings report, beating expectations of €0.913. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Hannover Rueck SE?
Currently, no hedge funds are holding shares in DE:HNRB
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Hannover Rueck SE Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
25.68%
12-Months-Change
Fundamentals
Return on Equity
4.99%
Trailing 12-Months
Asset Growth
4.47%
Trailing 12-Months
Company Description
Hannover Rueck SE
Hannover Rück SE, through its network of global subsidiaries, functions as a prominent international supplier of extensive reinsurance solutions and related services. Its business operations are primarily divided into two main areas: Property & Casualty Reinsurance and Life & Health Reinsurance. Within the Property & Casualty division, the company delivers a wide array of offerings. These include general property and casualty coverage, bespoke facultative reinsurance, protection against major catastrophic events (known as catastrophe XL), intricate structured reinsurance programs, and innovative insurance-linked securities. Moreover, it devises specialized risk management strategies for specific industries such as agriculture, livestock, and bloodstock; aviation and space endeavors; marine and offshore energy ventures; and complex exposures like credit, surety, and political risks. In the Life & Health sector, Hannover Rück provides reinsurance for various products, including group and individual credit life policies, enhanced annuity options, group life and health plans, and Takaful (Islamic insurance) products. It further extends its expertise to risk solutions concerning critical illness, disability, general health, longevity, long-term care, mortality, and morbidity. Beyond its core reinsurance activities, the firm also offers a suite of financial solutions. These encompass funding for new business initiatives, unlocking embedded value, providing crucial reserve and solvency relief, and facilitating the divestiture of non-essential business segments. Established in 1966 and based in Hanover, Germany, the company adopted its current name, Hannover Rück SE, in March 2013, having previously been known as Hannover Rückversicherung AG. It operates as a subsidiary of Talanx AG.
HNRB Company Deck
HNRB Earnings Call
Q2 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed strong operational and financial results: solid group net income (EUR 1.4bn), P&C combined ratio well inside target (83.2%), ROI above target (3.7%), robust solvency (254%) and significant premium/CSM growth across business lines. Management acknowledged market headwinds — notably rate softening (risk-adjusted price decline ~4%), structured reinsurance volume reductions, IFRS 17 reporting effects on revenue, and localized claim/assumption pressures in Life & Health — but emphasized prudent reserving, ample large-loss buffers (~EUR 1.5bn remaining), and confidence in delivering 2026 guidance. Overall, the positives (profitability, capital strength, growth in renewals/CSM and investment yield) outweigh the challenges, with management framing the negatives as manageable and addressed through underwriting discipline and reserve prudence.View all DE:HNRB earnings summariesTechnical Analysis
1 Day
3 Days
1 Week
1 Month
American International Group
―
Arch Capital Group
―
Everest Group
―
Reinsurance Group
―
Renaissancere Holdings
―









